PATENT CLAIM ANALYSIS

Application Number: 15510478
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2017-10
Patent Classification: ["424", "489000"]

Abstract:
Described herein are methods for treating or preventing a disease or disorder of the pulmonary system (e.g., cystic fibrosis), respiratory or digestive system in a subject, the methods comprising administering compounds or compositions comprising water soluble polyglucosamine and derivatized polyglucosamine.

Claim (Index 66):
The method of  claim 62 , wherein the composition is administered in an amount (e.g, a volume, e.g., nebulized solution volume) sufficient to provide about 0.2 mg to about 3 mg to the subject.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 90.0
- Lexical Diversity: 1.31429
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12617716', '12567571', '12541584', '13984991', '13566816']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7220258822185253
- 35 USC 102 Novelty (BERT): 0.5182617877347754
- Combined Prediction Score: 0.7016494727701502
- Mean Citation Score: 233.39407000000003
- Max Citation Score: 265.4542
- Similarity Product: 153.29088874589206

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test